home / stock / fdmt / fdmt articles

FDMT Articles, 4D Molecular Therapeutics Inc. - From 01/29/24

Stock Information
Company Name: 4D Molecular Therapeutics Inc.
Stock Symbol: FDMT
Market: NASDAQ
Website: 4dmoleculartherapeutics.com
Menu
FDMT FDMT Quote FDMT Short FDMT News FDMT Articles FDMT Message Board
Get FDMT Alerts

News, Short Squeeze, Breakout and More Instantly...
4DMT to Host Corporate Webcast to Discuss Interim Data from Phase 2 PRISM Clinical Trial of Intravitreal 4D-150 in Wet AMD Patients with Severe Disease Activity & High Treatment Burden | Benzinga

Initial interim landmark data analysis (N=50 at 24 Weeks) will be presented by Arshad M. Khanani, M.D., M.A., FASRS, Principal Investigator of th...
Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings. KMX reported a t...

4DMT to Present Interim Data from Aerosolized 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibrosis at 2023 NACFC | Benzinga

4D-710 interim data to be presented in plenary and symposium sessions at the North American Cystic Fibrosis Conference in Phoenix, Arizona held o...

4DMT Receives EMA Priority Medicines (PRIME) Designation for 4D-150 Clinical-Stage Genetic Medicine for Treatment of Wet AMD | Benzinga

The European Medicines Agency's priority medicines status is granted to drug candidates that may offer a major therapeutic advantage over ex...
Abbott Laboratories, Nasdaq, Spirit AeroSystems And Other Big Stocks Moving Higher On Wednesday | Benzinga

U.S. stocks traded lower, with the Dow Jones falling around 50 points on Wednesday. Here are some big stocks recording gains in today’s sessi...

4DMT Appoints Uneek Mehra as Chief Financial and Business Officer | Benzinga

EMERYVILLE, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (NASDAQ:FDMT, 4DMT or the Company)), a clinical-stage biothera...

4DMT to Participate in Upcoming Investor Conferences | Benzinga

EMERYVILLE, Calif., Sept. 07, 2023 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT, 4DMT)), a clinical-stage biotherapeutics co...
Previous 10 Next 10